Novo CEO pressed by Senate to cut selling prices of obesity, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would contemplate new talks with insurers with regard to the list price ranges of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. https://aya-healthcare-address27261.vidublog.com/29938519/the-smart-trick-of-healthcare-news-that-nobody-is-discussing